Skip to main content
Retour
Watch Compare

BIO-PATH HOLDINGS, INC.

Qualité des données : 83%
BPTH
OTC Manufacturing Chemicals
0,06 €
0,00 € (0,00%)
Cap. Boursière: 467 107,0
Prix
0,05 €
Cap. Boursière
467 107,0
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -4,48 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,08
Interest CoverageN/A

Valorisation

PE (TTM)
-0,04
Au-dessus de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E 0,0 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q22025 -0,40 € -0,55 € -37,5%
Q12025 -0,38 € -0,40 € -5,3%
Q42024 -0,37 € -0,07 € +81,1%
Q32024 -1,02 € -0,70 € +31,4%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -11,18 M
ROE N/A ROA -1556,82%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -4,48 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,08
Interest Coverage N/A Asset Turnover N/A
Working Capital -8,02 M Tangible Book Value -8,00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,04 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -958,45%
Market Cap 467 107,0 Enterprise Value 467 107,0
Per Share
EPS (Diluted TTM) -1,14 Revenue / Share N/A
FCF / Share -0,48 OCF / Share -0,48
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 40,05%
SBC-Adj. FCF -4,77 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -9,89 M -16,08 M -13,87 M -10,44 M -10,88 M
EPS (Diluted) -4,12 -33,63 -1,91 -1,55 —
Gross Profit — — — — —
Operating Income -11,99 M -15,84 M -13,90 M -10,44 M -10,91 M
EBITDA — — — — —
R&D Expenses 7,30 M 11,61 M 9,17 M 5,91 M 6,58 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3,88 M 3,22 M 15,97 M 26,57 M 16,48 M
Total Liabilities 3,73 M 2,78 M 1,80 M 1,11 M 1,41 M
Shareholders' Equity 154 000,0 441 000,0 14,17 M 25,46 M 15,07 M
Total Debt — — — — —
Cash & Equivalents — — — — —
Current Assets 3,78 M 3,04 M 15,62 M 26,14 M 15,96 M
Current Liabilities 3,30 M 1,91 M 1,68 M 958 000,0 1,17 M